Fucikova, J.; Truxova, I.; Hensler, M.; Becht, E.; Kasikova, L.; Moserova, I.; Vosahlikova, S.; Klouckova, J.; Church, S.E.; Cremer, I.; Kepp, O.; Kroemer, G.; Galluzzi, L.; Salek, C.; Spisek, R.

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

[rok vydání 2017, impact factor 13.164 ]

Polivkova, V.; Benesova, A.; Zizkova, H.; Koblihova, J.; Curik, N.; Motlova, E.; Klamova, H.; Salek, C.; Machova Polakova, K.

Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells

[rok vydání 2021, impact factor 11.528 ]

Truxova, I.; Kasikova, L.; Salek, C.; et al.

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients

[rok vydání 2020, impact factor 9.941 ]

Rakova, J.; Truxova, I.; Holicek, P.; Salek, C.; Hensler, M.; Kasikova, L.; Pasulka J.; Holubova, M.; Kovar, M.; Lysak, D.; Kline, J.P.; Racil, Z.; Galluzzi, L.; Spisek, R.; Fucikova, J.

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

[rok vydání 2021, impact factor 8.110 ]

Kuželová, K.; Brodská, B.; Marková, J.; Petráčková, M.; Schetelig, J.; Ransdorfová, Š.; Gašová, Z.; Šálek, C.

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia

[rok vydání 2022, impact factor 8.110 ]

Šálek, C.; Folber, F.; Froňková, E.; Pecherková, P.; Jelínková, H.; Hrabovský, Š.; Horáček, J.M.; Cetkovský, P.; Mayer, J.; Trka, J.; Doubek, M.

Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant

[rok vydání 2021, impact factor 6.998 ]

Šestáková, Š.; Cerovská, E.; Cyril Šálek, C.; Kundrát, D.; Ježíšková, I.; Folta, A.; Mayer, J.; Ráčil, Z.; Cetkovský, P.; Remešová, H.

A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel

[rok vydání 2022, impact factor 6.551 ]

Curik, N.; Polivkova, V.; Burda, P.; Koblihova, J.; Laznicka, A.; Kalina, T.; Kanderova, V.; Brezinova, J.; Ransdorfova, S.; Karasova, D.; Rejlova, K.; Bakardjieva, M.; Kuzilkova, D.; Kundrat, D.; Linhartova, J.; Klamova, H.; Salek, C.; Klener, P.; Hrusak, O.; Machova Polakova, K.

Somatic mutations in oncogenes are in chronic myeloid leukemia acquired de novo via deregulated base-excision repair and alternative non-homologous end joining

[rok vydání 2021, impact factor 6.244 ]

Fucikova, J.; Moserova, I.; Urbanova, L.; Bezu, L.; Kepp, O.; Cremer, I.; Salek, C.; Strnad, P.; Kroemer, G.; Galluzzi, L.; Spisek, R.

Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer

[rok vydání 2015, impact factor 5.695 ]

Chiaretti, S.; Messina, M.; Grammatico, S.; Piciocchi, A.; Fedullo, A.L.; Di Giacomo, F.; Peragine, N.; Gianfelici, V.; Lauretti, A.; Bareja, R.; Martelli, M.P.; Vignetti, M.; Apicella, V.; Vitale, A.; Li, L.S.; Salek, C.; et al.

Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications

[rok vydání 2018, impact factor 5.206 ]

Hájková, H.; Fritz, M.H-Y.; Haškovec, C.; Schwarz, J.; Šálek, C.; Marková, J.; Krejčík, Z.; Dostálová Merkerová, M.; Kostečka, A.; Vostrý, M.; Fuchs, O.; Michalová, K.; Cetkovský, P.; Beneš, V.

CBFB - MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia

[rok vydání 2014, impact factor 4.812 ]

Brodská, B.; Otevřelová, P.; Šálek, C.; Fuchs, O.; Gašová, Z.; Kuželová, K.

High PD-L1 expression predicts for worse outcome of leukemia patients with concomitant NPM1 and FLT3 mutations

[rok vydání 2019, impact factor 4.556 ]

Hrabovsky, S.; Vrzalova, Z.; Stika, J.; Jelinkova, H.; Jarosova, M.; Navrkalova, V.; Martenek, J.; Folber, F.; Salek, C.; Horacek, J.M.; Pospisilova, S.; Mayer, J.; Doubek, M.

Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype

[rok vydání 2021, impact factor 4.089 ]

Šestáková, Š.; Krejčík, Z.; Folta, A.; Cerovská, E.; Šálek, C.; Dostálová Merkerová, M.; Pecherková, P.; Ráčil, Z.; Mayer, J.; Cetkovský, P.; Remešová, H.

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations

[rok vydání 2019, impact factor 3.436 ]

Šálek, C.; Vydra, J.; Cerovská, E.; Šestáková, Š.; Ransdorfová, Š.; Válková, V.; Cetkovský, P.; Remešová, H.

WT1 expression in peripheral blood at diagnosis and during the course of early consolidation treatment correlates with survival in patients with intermediate and poor-risk acute myeloid leukemia

[rok vydání 2020, impact factor 3.231 ]

Valkova, V.; Vydra, J.; Markova, M.; Cerovska, E.; Vrana, M.; Marinov, I.; Cechova, H.; Cetkovsky, P.; Vitek, A.; Salek, C.

WT1 gene expression in peripheral blood before and after allogeneic stem cell transplantation is a clinically relevant prognostic marker in AML: a single-center 14-year experience

[rok vydání 2020, impact factor 3.231 ]

Neupauerová, J.; Vraná, M.; Ratajová, E.; Nazarová, S.; Půbalová, Š.; Šálek, C.; Crivello, P.; Březinová, J.; Beličková, M.; Dyr, J.E.

The formation of a somatic mutation in the HLA-B gene throughout the development of the disease from severe aplastic anaemia to acute myeloid leukaemia

[rok vydání 2019, impact factor 2.955 ]

Burda, P.; Vargova, J.; Curik, N.; Salek, C.; Papadopoulos, G.L.; Strouboulis, J.; Stopka, T.

GATA-1 inhibits PU.1 gene via DNA and histone H3K9 methylation of its distal enhancer in erythroleukemia

[rok vydání 2016, impact factor 2.806 ]

Kuželová, K.; Brodská, B.; Schetelig, J.; Röllig, C.; Ráčil, Z.; Stickel Walz, J.; Helbig, G.; Fuchs, O.; Vraná, M.; Pecherková, P.; Šálek, C.; Mayer, J.

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

[rok vydání 2018, impact factor 2.776 ]

Šestáková, Š.; Šálek, C.; Remešová, H.

DNA methylation validation methods: a coherent review with practical comparison

[rok vydání 2019, impact factor 2.711 ]

Trněný, M.; Čermák, J.; Klamová, H.; Šálek, C.; Cieslar, P.; Salaj, P.; Kvasnička, J.; Písačka, M.; Gašová, Z.

Hematologie

[rok vydání 2016]